AI-generated summary
The authors studied 808 nm photobiomodulation in spontaneously hypertensive rats, a model of ADHD, over 21 days compared with sham treatment and normal control rats. They report reduced movement measures in open-field testing, higher prefrontal fractional anisotropy, fewer Iba-1 positive microglia and preserved myelin. The study was conducted in animals, and the authors call for further studies before clinical use.
- Who or what was studied
- Spontaneously hypertensive rats (SHR) as an ADHD animal model, with normal control WKY rats; total number of animals not stated in the abstract.
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The study was conducted in an animal model, the total number of animals is not stated, and the authors state that clinical applicability and long-term safety in humans require further study.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Attention-deficit/hyperactivity disorder, Photobiomodulation therapy, Photobiomodulation, Sham, Neuroinflammation, Control group, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.